Mouse glioma gene expression profiling identifies novel human glioma-associated genes

Annals of Neurology

Volumn 51, Issue 3, 2002, Pages 393-405

  Gutmann, David H ^a   Huang, Zhi Yong ^b   Hedrick, Nicolé M ^c   Ding, Hao ^c   Guha, Abhijit ^a   Watson, Mark A ^b  

^a Department of Neurology ^*  (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAS PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOMA; CANCER GRADING; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENIC MOUSE; TUMOR CELL LINE; UNINDEXED SEQUENCE;

ANIMALS; ASTROCYTOMA; BRAIN NEOPLASMS; CELL DIVISION; CELLS, CULTURED; GAP-43 PROTEIN; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENES, RAS; GLIOBLASTOMA; GLIOMA; HUMANS; MICE; MICE, TRANSGENIC;

EID: 0036192709     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10145     Document Type: Article

References (67)

1. Intracranial gliomas in NF1
2. Rhabdomyosarcoma in children: Epidemiologic study and identification of a familial cancer syndrome
3. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/akt signaling in a neurofibromatosis 1 astrocytoma
4. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas
5. Loss of wild-type p53 bestows a growth advantage on primary cortical astrocytes and facilitates their in vitro transformation
6. Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro
7. Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas
8. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2
9. CDKN2/p16 or RB alterations occur in the majority, of glioblastomas and are inversely correlated
10. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas
11. Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme
12. Differential modulation of mitogen-activated protein (MAP) kinase/extracellular signal-related kinase and MAP kinase activities by a mutant epidermal growth factor receptor
13. Astrocyte-specific expression of activated Ras results in malignant astrocytomas in a transgenic mouse model of human gliomas
14. Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes
15. Increased expression of the neurofibromatosis 1 (NF1) tumor suppressor protein, neurofibromin, in reactive astrocytes in vitro
16. A high-density probe array sample preparation method using 10- to 100-fold fewer cells
17. Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas
18. Global analysis of differential gene expression after transformation with the v-H-ras oncogene in a murine rumor model
19. Application of the differential hybridization of Arias human expression arrays technique in the identification of differentially expressed genes in human glioblastoma multiforme tumor tissue
20. Growth and migration markers of rat C6 glioma cells identified by serial analysis of gene expression
21. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques
22. Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays
23. Proliferation of human malignant astrocytomas is dependent on Ras activation
24. Annexin VII: An astroglial protein exhibiting a calcium dependent subcellular distribution
25. Polysialyltransferase ST8Sia II (STX) polysialylates all of the major isoforms of NCAM and facilitates neurite outgrowth
26. Lasp-1, a novel type of acrin-binding protein accumulating in cell membrane extensions
27. Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes
28. Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo
29. Transforming growth factor-beta and p-21: Multiple molecular targets of decorin-mediated suppression of neoplastic growth
30. The biology of Stat4 and Stat6
31. The chemokine growth-regulated oncogene alpha promotes spinal cord oligodendrocyte precursor proliferation
32. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration, and angiogenesis by a host CXC receptor-2 dependent mechanism
33. Expression patterns of Notch1, Notch2, and Notch3 suggest multiple functional roles for the Notch-DSL signaling system during brain development
34. Notch1 and Notch3 instructively restrict bFGF-responsive multipotent progenitor cells to an astroglial fate
35. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes
36. Up-regulation of lipocortin-1 and its mRNA in reactive astrocytes in kainatelesioned rat cerebellum
37. Gene expression of apolipoprotein E in human brain tumors
38. Glial responses, clusterin and complement in permanent focal cerebral ischemia in the mouse
39. The in vitro motility of human gliomas increases with increasing grade of malignancy
40. Functional characterization of beta isoforms of murine Na, K-ATPase. The adhesion molecule on glia (AMOG/beta 2), but not beta 1, promotes neurite outgrowth
41. Biochemical and functional characterization of a novel neuron-glia adhesion molecule that is involved in neuronal migration
42. DSD-1 proteoglycan is the mouse homolog of phosphacan and displays opposing effects on neurite outgrowth dependent on neuronal lineage
43. Expression of DSD-1 PG in primary neural and glial derived cell cultures, upregulation by TGF-beta, and implications for cell-substrate interactions of the glial cell line Oli-neu
44. Astrotactin: A novel neuronal cell surface antigen that mediates neuron-astroglial interactions in cerebellar microcultures
45. CNS gene encoding astrotactin, which supports neuronal migration along glial fibers
46. Gem: An induced, immediate early protein belonging to the Ras family
47. The Gem GTP-binding protein promotes morphological differentiation in neuroblastoma
48. Neural tube defects and abnormal brain development in F52-deficient mice
49. Overexpression of the myristoylated alanine-rich C kinase substrate in human choroidal melanoma cells affects cell proliferation
50. Growth-associated protein 43 is down-regulated in cultured astrocytes
51. Phosphorylation-site mutagenesis of the growth-associated protein GAP-43 modulates its effects on cell spreading and morphology
52. GAP43, MARCKS, and CAP23 modulate PI(4, 5)P2 at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism
53. Severely decreased MARCKS expression correlates with RAS reversion but not with mitogen responsiveness
54. Glycosyl phosphatidylinositol-anchored T-cadherin mediates calcium-dependent, homophilic cell adhesion
55. Inhibition of motor axon growth by T-cadherin substrata
56. Expression of T-cadherin (CDH13, H-cadherin) in human brain and its characteristics as a negative growth regulator of epidermal growth factor in neuroblastoma cells
57. Differential upregulation of aquaporin-4 mRNA expression in reactive astrocytes after brain injury: Potential role in brain edema
58. Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord
59. Regulation of aquaporin-4 expression in astrocytes
60. Sequence and location of SIX3, a homeobox gene expressed in the human eye
61. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin
62. HNMP-1: A novel hematopoietic and neural membrane protein differentially regulated in neural development and injury
63. Cloning of mouse FGF10 and upregulation of its gene expression during wound healing
64. Co-expression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance
65. Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop
66. Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells